Physician profile
Dipan Shah
NPI 1114966470
$89,864.86
in general payments reported to CMS, 2019-2025
29 companies · $642 in 2025
The $642 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,583 · 2021: $2,044 · 2022: $19K · 2023: $27K · 2024: $20K · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Travel and Lodging: $7,671 · Food and Beverage: $3,613 · Consulting Fee: $1,499 · Honoraria: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,078.34 |
| Travel and Lodging | $7,670.55 |
| Food and Beverage | $3,613.03 |
| Consulting Fee | $1,499.31 |
| Honoraria | $1,005.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $36,776.78 | 2021-2023 | Arcalyst |
| Siemens Medical Solutions USA, INC. | $27,166.37 | 2019-2025 | Naeotom Alpha, Magnetom Sola, Syngo Dynamics |
| Kiniksa Pharmaceuticals International, Plc | $15,489.86 | 2024 | Arcalyst |
| Amgen INC. | $5,066.97 | 2019-2025 | Repatha, Repatha |
| Guerbet LLC | $2,470.89 | 2024 | Elucirem |
| Ge Healthcare | $559.25 | 2019-2025 | |
| Jenavalve Technology, INC. | $399.31 | 2024 | |
| Novartis Pharmaceuticals Corporation | $385.34 | 2022-2024 | |
| Pfizer INC. | $284.37 | 2019-2024 | |
| Abbott Laboratories | $197.41 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $155.85 | 2023-2024 | Definity |
| Astellas Pharma US INC | $137.38 | 2019-2020 | |
| Heartflow, INC. | $104.27 | 2023 | Ffrct |
| Impulse Dynamics (USA) INC. | $103.18 | 2023 | Optimizer |
| Medtronic Vascular, INC. | $76.39 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $71.59 | 2025 | Attruby |
| Canon Medical Systems USA, INC. | $67.51 | 2019 | |
| Tactile Systems Technology INC | $64.87 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Edwards Lifesciences Corporation | $48.97 | 2025 | |
| Alnylam Pharmaceuticals INC. | $38.73 | 2019-2020 | |
| Baxter Healthcare | $37.98 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $36.57 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $32.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.31 | 2024 | Camzyos |
| Boston Scientific Corporation | $21.03 | 2019 | |
| Ethicon US, LLC | $17.20 | 2019 | |
| Sandoz INC. | $16.37 | 2019 | |
| Bracco Diagnostics INC. | $15.84 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipan Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.